ObsEva SA
(NASDAQ : OBSV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-1.59%132.800.7%$1050.52m
BMYBristol-Myers Squibb Co.
-1.20%57.891.4%$762.69m
MRKMerck & Co., Inc.
-0.45%84.520.7%$750.04m
PFEPfizer Inc.
-0.20%37.210.9%$725.85m
ABBVAbbVie, Inc.
0.49%89.062.3%$705.62m
LLYEli Lilly & Co.
0.00%113.191.1%$394.23m
NVSNovartis AG
0.01%90.050.2%$152.08m
AZNAstraZeneca Plc
1.15%47.991.2%$150.59m
RETAReata Pharmaceuticals, Inc.
-0.46%198.003.7%$143.57m
GSKGlaxoSmithKline Plc
0.85%44.470.2%$120.81m
NVONovo Nordisk A/S
-0.50%57.000.1%$78.34m
SNYSanofi
0.48%46.330.2%$64.85m
RARXRa Pharmaceuticals, Inc.
0.15%46.820.8%$39.47m
CNSTConstellation Pharmaceuticals, Inc.
1.35%39.000.0%$31.17m
BHVNBiohaven Pharmaceutical Holding Co. Ltd.
-1.16%50.490.0%$24.81m

Company Profile

ObsEva SA engages in the development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.